Back to top
more

Vanguard Health Care ETF: (VHT)

(Real Time Quote from BATS) As of Oct 18, 2024 03:53 PM ET

$281.05 USD

281.05
55,235

+1.15 (0.41%)

Volume: 55,235

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

1 - Strong Buy of 5 1        

Zacks News

Sweta Killa headshot

5 ETFs to Buy on JNJ's Q2 Earnings Strength

Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.

Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?

Smart Beta ETF report for FXH

Sweta Killa headshot

UnitedHealth Beats Q2 Earnings, Updates View: ETFs to Gain

UnitedHealth (UNH) reported better-than-expected second-quarter 2023 results, breezing past the Zacks Consensus Estimate for earnings and revenues. The company lifted the lower end of its full-year earnings guidance.

Should You Invest in the Vanguard Health Care ETF (VHT)?

Sector ETF report for VHT

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

Smart Beta ETF report for RSPH

Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?

Smart Beta ETF report for RYH

Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?

Smart Beta ETF report for FXH

Should You Invest in the Vanguard Health Care ETF (VHT)?

Sector ETF report for VHT

Sweta Killa headshot

5 Defensive Investment ETF Strategies for Your Portfolio

A defensive investment in the stock market is designed to minimize risk and protect your portfolio during market downturns.

Sweta Killa headshot

Don't "Sell in May And Go Away," Consider 5 ETF Strategies

"Sell in May and Go Away" is a popular Wall Street adage, denoting traditional market underperformance during summer months (May to October). Investors might consider several investment strategies to navigate the May-October period more effectively that could lead to a winning portfolio.

Sweta Killa headshot

ETFs to Buy on Solid Q1 JNJ Earnings Results

Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.

Sweta Killa headshot

UnitedHealth's Solid Q1 Earnings Put These ETFs in Focus

UnitedHealth Group reported better-than-expected first-quarter 2023 results, breezing past the Zacks Consensus Estimate for earnings and revenues.